Biostem Tech
Price
Prix
Questions fréquentes
Quelle est la capitalisation boursière de Biostem Tech ?
Quel est le ratio cours/bénéfice (P/E) de Biostem Tech ?
Quel est le bénéfice par action (BPA) de Biostem Tech ?
Quelles sont les évaluations des analystes et le prix cible de l'action Biostem Tech ?
Quel est le chiffre d'affaires de Biostem Tech sur les douze derniers mois ?
Quel est l'EBITDA de Biostem Tech ?
Quel est le bêta à 5 ans de l'action Biostem Tech ?
Combien d'employés compte Biostem Tech, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Biostem Tech ?
Finances
Capitalisation boursière
196,65 M $USbêta sur 5 ans
1,46BPA (TTM)
0,63 $USFree Float
16,05 MRatio P/E (TTM)
19,10Recettes (TTM)
210,39 M $USEBITDA (TTM)
20,73 M $USCotation
Notes des analystes
Informations
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.
67
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire